SCHEMBL1102938

SCHEMBL1102938

c1ccc2c(c1)oc1c(-c3c4ccccc4c(-c4cccc5c4oc4ccccc45)c4ncccc34)cccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.46
▸ KDM4E B2RXH2 4/20 0.41
▸ MAPT P10636 4/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ GAA P10253 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ PRKDC P78527 3/20 0.39
▸ PIK3CD O00329 1/20 0.39
▸ PIK3CB P42338 1/20 0.39
▸ LMNA P02545 2/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ USP2 O75604 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ LIMK1 P53667 1/20 0.39
▸ DRD4 P21917 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1103229 0.93 KDM4E (0.49) ALOX5KDM4EMAPTALDH1A1GAA
SCHEMBL1103050 0.92 ALOX5 (0.44) ALOX5KDM4EMAPTALDH1A1GAA
SCHEMBL9890833 0.85 ALOX5 (0.57) ALOX5KDM4EMAPTALDH1A1HPGD
SCHEMBL1103175 0.85 ALOX5 (0.44) ALOX5KDM4EMAPTALDH1A1GAA
SCHEMBL1102878 0.85 KDM4E (0.41) ALOX5KDM4EMAPTALDH1A1GAA
SCHEMBL24621707 0.84 ALOX5 (0.48) ALOX5KDM4EMAPTALDH1A1GAA
SCHEMBL21450759 0.84 ALOX5 (0.56) ALOX5KDM4EMAPTALDH1A1HPGD
SCHEMBL24621709 0.83 ALOX5 (0.47) ALOX5KDM4EMAPTALDH1A1GAA
SCHEMBL22854844 0.80 ALOX5 (0.57) ALOX5KDM4EMAPTALDH1A1HPGD
SCHEMBL15075201 0.80 ALOX5 (0.42) ALOX5KDM4EMAPTALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 — — US disclosed
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 — — US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 — — US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same ORMDL3, OCIAD2, OCIAD1 ALOX5 9/4885KDM4E 3367/4885MAPT 3162/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback